Condyloma Acuminatum — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for condyloma acuminatum. 10 active patents protecting 1 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

1
Approved drugs
10
Active US patents
73/100
Avg vulnerability
—
Annual revenue covered

Originators in Condyloma Acuminatum

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Bausch Health 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating condyloma acuminatum. Each bar = one year. Y-axis scaled to peak year (7 patents).

7
29
3
30

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Aldara
IMIQUIMOD
 Bausch Health 10 73 — 2029-08-18

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11850245 Aldara method of use 81 2030-04-30
11318130 Aldara method of use 76 2029-12-11
11202752 Aldara method of use 76 2030-04-30
8598196 Aldara method of use 73 2029-08-18
8236816 Aldara method of use 73 2029-12-11
8222270 Aldara method of use 73 2029-12-11
8299109 Aldara method of use 73 2029-12-11
10238645 Aldara method of use 68 2029-08-18
10238644 Aldara method of use 68 2029-12-11
10918635 Aldara method of use 68 2030-04-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10918635 Aldara method of use 68 2030-04-30
10238644 Aldara method of use 68 2029-12-11
10238645 Aldara method of use 68 2029-08-18
8236816 Aldara method of use 73 2029-12-11
8222270 Aldara method of use 73 2029-12-11
8299109 Aldara method of use 73 2029-12-11
8598196 Aldara method of use 73 2029-08-18
11202752 Aldara method of use 76 2030-04-30
11318130 Aldara method of use 76 2029-12-11
11850245 Aldara method of use 81 2030-04-30

Related